Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/19/2013WO2013188279A1 Topical ophthalmological pharmaceutical composition containing cediranib
12/19/2013WO2013188273A1 Topical ophthalmological pharmaceutical composition containing axitinib
12/19/2013WO2013188268A1 Topical ophthalmological pharmaceutical composition containing pazopanib
12/19/2013WO2013188258A1 Use of hmb to improve health outcomes for hospitalized patients
12/19/2013WO2013188217A1 Therapeutic formulation and methods of treatment
12/19/2013WO2013188214A1 Compounds for treating inflammation and pain
12/19/2013WO2013188210A2 Treatment of motor and movement disorder side effects associated with parkinson's disease treatments
12/19/2013WO2013188184A1 Inhibitor of jak1 and jak2
12/19/2013WO2013188138A1 Inhibitors of hippo-yap signaling pathway
12/19/2013WO2013188073A1 Use of heparin and carbohydrates to treat cancer
12/19/2013WO2013188013A1 Method and system for operating a patient ventilation device
12/19/2013WO2013187983A1 Methods an compositions for treating or diagnosing melanoma
12/19/2013WO2013187978A1 Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
12/19/2013WO2013187967A1 Sensitization of cancer cells to dna damage by inhibiting kinases essential for dna damage checkpoint control
12/19/2013WO2013187965A1 Pyrazole derivatives as inhibitors of stat3
12/19/2013WO2013187954A1 Magnetic labeling of bacteria
12/19/2013WO2013187891A1 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
12/19/2013WO2013187795A1 Pharmaceutical composition of an s1p receptor agonist for treating demyelinized disorders
12/19/2013WO2013187764A1 Fermented infant formula with non digestible oligosaccharides
12/19/2013WO2013187755A1 Fermented infant formula with non digestible oligosaccharides
12/19/2013WO2013187727A1 Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
12/19/2013WO2013187720A1 Novel composition for the treatment of gastroesophageal reflux disease
12/19/2013WO2013187700A1 Pharmaceutical combined formulation comprising metformin and hmg-coa reductase inhibitor
12/19/2013WO2013187696A1 Indole based compound having selective inhibiting activity on genome replication of hepatitis c virus, production method for same, and pharmaceutical composition for preventing or treating hepatitis c containing same as active ingredient
12/19/2013WO2013187673A1 Complex vitamin conjugate and antioxidant comprising same
12/19/2013WO2013187665A1 Pharmaceutical composition for treating wounds or revitalizing skin comprising euphorbia kansui extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient
12/19/2013WO2013187646A1 Piperidine derivatives for gpr119 agonist
12/19/2013WO2013187626A1 Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same
12/19/2013WO2013187612A1 Composition for restricting apoptosis, including mirna of epstein-barr virus, or promoting cell proliferation
12/19/2013WO2013187576A1 Composition comprising silymarin as active ingredient for preventing and treating peptic ulcers caused by alcohol consumption
12/19/2013WO2013187575A1 Composition comprising hypothemycin as active ingredient for preventing and treating macrophage activation syndrome, hepatocirrhosis, or obesity
12/19/2013WO2013187533A1 Heteroarylcarboxylic acid ester derivative
12/19/2013WO2013187503A1 Glycine transporter inhibitor
12/19/2013WO2013187467A1 Heteroaromatic methyl cyclic amine derivative
12/19/2013WO2013187466A1 Branched chain alkyl heteroaromatic ring derivative
12/19/2013WO2013187462A1 Piperidinylpyrazolopyridine derivative
12/19/2013WO2013187451A1 Patch
12/19/2013WO2013187395A1 Tablet having ingestion easiness and dividability
12/19/2013WO2013187391A1 COMPOSITION COMPRISING SESAMIN COMPOUND, γ-ORIZANOL AND RICE GERM OIL
12/19/2013WO2013187088A1 Method for producing powder for inhalation
12/19/2013WO2013187075A1 Prophylactic and/or therapeutic agent for mild cognitive impairment
12/19/2013WO2013187069A1 Pdt effect enhancing agent
12/19/2013WO2013187052A1 Anti-colon cancer agent
12/19/2013WO2013186857A1 Aptamer to fgf2 and use thereof
12/19/2013WO2013186777A2 Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
12/19/2013WO2013186746A1 Desethylamiodarone compositions
12/19/2013WO2013186734A1 Chemoprevention of colorectal cancer
12/19/2013WO2013186692A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
12/19/2013WO2013186680A1 Feijoa fruit extract
12/19/2013WO2013186666A1 Tricyclic compounds as kat ii inhibitors
12/19/2013WO2013186612A1 The use of substituted 2-phenyl-3h-quinazolin-4-ones and analogs for inhibiting bet (bromodomain and extra terminal domain) proteins
12/19/2013WO2013186607A1 Method of using boronic acid teboroxime for pharmacologic myocardial perfusion spect studies with specific compositions, unit dosage forms and kits
12/19/2013WO2013186570A1 Nutritional product
12/19/2013WO2013186546A1 Complexes of amphotericin b with poly (glutamic acid)
12/19/2013WO2013186493A2 Composition, in an aqueous medium, including at least one hyaluronic acid and at least one sucrose octasulphate water-soluble salt
12/19/2013WO2013186399A1 V1b receptor antagonist for use in the treatment of patients having an elevated avp level and/or an elevated copeptin level
12/19/2013WO2013186384A1 N-substituted second generation derivatives of antifungal antibiotic amphotericin b and methods of their preparation and application
12/19/2013WO2013186370A1 Oral pharmaceutical formulation of bcs class iii molecules
12/19/2013WO2013186355A1 A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
12/19/2013WO2013186335A1 1,3 -dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
12/19/2013WO2013186334A1 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
12/19/2013WO2013186333A1 1,3 -dihydro- 2h-benzimidazol- 2 -one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
12/19/2013WO2013186332A1 4 - substituted 1, 3 - dihydro - 2h - benzimidazol - 2 - one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
12/19/2013WO2013186326A1 NEW SYNTHETIC ROUTE FOR THE PREPARATION OF ß-AMINOBUTYRYL SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,4]DIAZOLO[4,3-alpha]PYRAZIN-7-YL COMPOUNDS
12/19/2013WO2013186320A1 Pharmaceutical composition comprising crystalline posaconazole
12/19/2013WO2013186311A1 Extended release formulations
12/19/2013WO2013186233A1 Composition
12/19/2013WO2013186229A1 Tnf -alpha modulating benzimidazoles
12/19/2013WO2013186220A1 Compositions comprising hesperidin and/or apigenin i.a. for medical use or for use in treatment of sleeping disorders
12/19/2013WO2013186191A1 Formulations of metronidazole for the treatment of pouchitis
12/19/2013WO2013186159A1 New diazaspirocycloalkane and azaspirocycloalkane
12/19/2013WO2013186153A2 Amidophenoxypropanolamines
12/19/2013WO2013186138A1 Preparation comprising insulin, nicotinamide and arginine
12/19/2013WO2013186109A1 2,3-dihydro-furo[2,3-c]pyridin-2-yl-piperidine derivatives, pharmaceutical compositions containing them and uses thereof
12/19/2013WO2013185934A1 Method of preparing a composition based on hyaluronic acid
12/19/2013WO2013185933A1 Pharmaceutical composition for liver regeneration
12/19/2013WO2013185789A1 Pharmaceutical composition containing phosphate binding polymer
12/19/2013WO2013185766A1 Gpr120 receptor modulators
12/19/2013WO2013185764A2 Pharmaceutical compositions for combination therapy
12/19/2013WO2013185635A1 Polyoxopregnane compounds and use thereof
12/19/2013WO2013185613A1 Acylation derivatives of paridis saponins i, preparation method therefor and application thereof
12/19/2013WO2013185507A1 Benzothiazine-4-one derivatives, preparation method therefor and use thereof
12/19/2013WO2013185505A1 Olanzapine oral instant membrane
12/19/2013WO2013185353A1 Compound as wnt signaling inhibitor, composition, and use thereof
12/19/2013WO2013185301A1 Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs
12/19/2013WO2013185294A1 Chinese medicine for preventing and treating rhagades and frostbite and preparation method thereof
12/19/2013WO2013185284A1 Pyridinone and pyridazinone derivatives
12/19/2013WO2013185241A1 Aptamers specific to cea and tnf-alpha and their therapeutic uses
12/19/2013WO2013185214A1 Pla2g7/lp-pla2 as biomarker and therapeutic target in the prevention and treatment of calcific aortic valve disease
12/19/2013WO2013185209A1 Forms of vilazodone and processes for the preparation thereof
12/19/2013WO2013185202A1 Apoptosis inducers
12/19/2013WO2013156387A3 Water resistant compositions containing a heterocyclic compound and an alkoxysilane
12/19/2013WO2013155485A3 Method of using cyclodextrin
12/19/2013WO2013152120A3 Compositions and methods for promoting intestinal stem cell function
12/19/2013WO2013151736A3 In vivo production of proteins
12/19/2013WO2013150545A3 Process for preparation of benzimidazole derivatives and salts thereof
12/19/2013WO2013144176A9 Controlled release formulation comprising mesalamine
12/19/2013WO2013127539A3 Pharmaceutical formulation containing flupirtin
12/19/2013WO2013114053A3 Extended-release pharmaceutical composition of trimetazidine
12/19/2013WO2013092448A3 Use of hydroxamic acids for stabilizing cosmetic and/or dermatological preparations
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 7860